Results 81 to 90 of about 23,951 (282)

Lipoprotein apheresis affects lipoprotein particle subclasses more efficiently compared to the PCSK9 inhibitor evolocumab, a pilot study.

, 2018
Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are last therapeutic resorts in patients with familial hypercholesterolemia (FH).
Karlsson, Helen, Ljunggren, Stefan A,, Marcusson-Ståhl, Maritha, Anders Hovland, Kjellmo, Christian Abendstein,, Cederbrant, Karin,, Mathisen, Monica,, Cederbrant, Karin, Mathisen, Monica, Lappegård, Knut Tore, Lappegård, Knut Tore,, Kjellmo, Christian Abendstein, Christian Abendstein Kjellmo, Maritha Marcusson-Ståhl, Marcusson-Ståhl, Maritha,, Knut Tore Lappegård, Stefan Ljunggren, Karin Cederbrant, Hovland, Anders, Helen Karlsson, Monica Mathisen, Karlsson, Helen,, Ljunggren, Stefan A, Hovland, Anders,   +23 more
core   +1 more source

Intra‐apheresis CD34+ cell count: A dynamic approach to predicting peripheral blood stem cell collection yield

Transfusion, EarlyView.
Abstract Background Accurate prediction of peripheral blood stem cell (PBSC) yield is essential for optimizing hematopoietic stem cell collections. Traditional CD34+ prediction formulas often overlook the ongoing recruitment of CD34+ cells during the collection procedure.
Abdullah Alswied, Linda Song, Mame Thioye‐Sall, Leonard N. Chen, Kamille West‐Mitchell, Nan Zhang, Ping Jin, David Stroncek, Anh Dinh   +8 more
wiley   +1 more source

Severe hyperlipoproteinemia(a) as a factor of rapidly progressive coronary artery disease in a young woman with heterozygous familial hypercholesterolemia

Российский кардиологический журнал, 2019
.
U. V. Chubykina, O. I. Afanasieva, N. T. Khachatryan, N. G. Kukava, V. P. Vasiliev, M. V. Ezhov   +5 more
doaj   +1 more source

Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness

Transfusion, EarlyView.
Abstract Background Platelet transfusion refractoriness (PTR) is a major challenge in transfusion medicine and may result from both immune and non‐immune mechanisms. Although alloantibodies are well‐established contributors, Fc‐independent pathways such as platelet desialylation have emerged as alternative mechanisms of clearance.
Karen Ziza, Thamy Silva, Mateus Domentino, Marina Conrado, João Oliveira, Elyse Moritz, Akemi Chiba, Vanderson Rocha, Alfredo Mendrone‐Junior, José Bordin, Langhi Dante, Carla Dinardo   +11 more
wiley   +1 more source

apheresis registry study on Wilson's disease

, 2016
Wilson's disease is a rare autosomal recessive genetic disorder that results in accumulation of copper in the liver, brain, cornea and kidney. Therapeutic plasma exchange (TPE) has been used to remove copper and provide a bridge to liver transplantation.
Kim, Haewon C, Wu, Yanyun, Chisa Yamada, Winters, Jeffrey L, Pham, Huy P, Huy P. Pham, Jeffrey L. Winters, Pagano, Monica B, Morgan, Shanna, Laura Cooling, Jan C. Hofmann, Jennifer Schneiderman, Yanyun Wu, Cooling, Laura, Haewon C. Kim, Monica B. Pagano, Edward C.C. Wong, Schneiderman, Jennifer, Schwartz, Joseph, Shanna Morgan, Hofmann, Jan C, Wong, Edward C C, Yamada, Chisa, Joseph Schwartz   +23 more
core   +1 more source

Alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: A potential clue for restoration of pathophysiology [PDF]

, 2010
Objectives: The potential influence of automated red cell exchange (ARCE) on endothelial activation is not well established. This study was intended to assess whether ARCE influences circulating endothelial cells (CECs) in patients with sickle cell ...
C. Bakar, Sozer, O., I. Kozanoglu, N. Sezgin, O. Sozer, Ozdogu, H., Sezgin, N., Boga, C., Kozanoglu, I., Bakar, C., C. Boga, H. Ozdogu   +11 more
core   +1 more source

The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review

Transfusion, EarlyView.
Abstract Background Acquired hypofibrinogenemia poses significant bleeding risks. Concentrated sources of fibrinogen, whether cryoprecipitate or fibrinogen concentrates, are widely used. This scoping review aimed to identify and map the available evidence on fibrinogen supplementation.
Aaron S. Hess, Sandra K. White, Elizabeth P. Crowe, Jay S. Raval, Jennifer Andrews, Claudia S. Cohn, Mischa L. Covington, Melissa M. Cushing, Cyril Jacquot, Jenna Khan, Anil K. Panigrahi, Nabiha H. Saifee, Aaron A. R. Tobian, Mary M. McFarland, Simon J. Stanworth, Ryan A. Metcalf   +15 more
wiley   +1 more source

Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors

Transfusion, EarlyView.
Abstract Background Granulocyte colony‐stimulating factor (G‐CSF)‐based mobilization is essential for peripheral blood stem cell (PBSC) collection for allogeneic transplantation. Conventional daily G‐CSF requires repeated dosing and dose adjustment and often necessitates leukapheresis over multiple consecutive days, increasing donor burden. Single‐dose
Tomoshige Shimizu, Tomoyasu Jo, Noriyoshi Yoshinaga, Takashi Sakamoto, Hiroyuki Matsui, Toshio Kitawaki, Junya Kanda, Momoko Nishikori, Kouhei Yamashita, Miki Nagao, Akifumi Takaori‐Kondo, Yasuyuki Arai   +11 more
wiley   +1 more source

Therapeutic plasma exchange performed in tandem with hemodialysis without supplemental calcium in the apheresis circuit

, 2017
Therapeutic plasma exchange (TPE) and hemopoietic progenitor cell (HPC) collection are apheresis procedures that can safely be performed in tandem with hemodialysis. Despite the return of citrate-anticoagulated blood to the patient during HPC collection,
Hickson, Elda, Greene, Mindy, Bailey, Jeffrey A., Vauthrin, Michelle, Haynes, Stefanie, Zhao, Yong, Ibrahim, Hiba, Weinstein, Robert, Linden, Jeanne   +8 more
core   +1 more source

Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks

, 2004
The use of therapeutic apheresis in very low weight patients is generally thought to have limitations, because of possible severe adverse reactions, potential risk related to the extracorporeal procedure, due to the low weight of the young patients.
Di Giacomo S., Lanti A., De Lorenzo F., ISACCHI, GIANCARLO, Stefanutti C., Lanti A., Di Giacomo S., Mareri M., De Lorenzo F., Landolfo A., Isacchi G., Landolfo A., Stefanutti C., Mareri M.   +7 more
core   +2 more sources